[1]
N. T. Dobrovolskienė, “Expression of tolerogenic potential-representing markers on clinical-grade therapeutic dendritic cell-based cancer vaccines”,
AML
, vol. 20, no. 4, pp. 161–173, Feb. 2014, doi:
10.6001/actamedica.v20i4.2813
.